PATENT CLAIM ANALYSIS

Application Number: 16109508
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["702", "019000"]

Abstract:
A dosing controller for administering insulin. The dosing controller includes a data processing device and non-transitory memory in communication with the data processing device. The dosing controller receives blood glucose measurements of a patient from the glucometer, receives patient information, selects a subcutaneous insulin treatment from a collection of subcutaneous insulin treatments based on the blood glucose measurements and the patient information, and executes the selected subcutaneous insulin treatment. Each blood glucose measurement is separated by a time interval and includes a blood glucose time associated with a time of measuring the blood glucose measurement.

Claim (Index 6):
The dosing controller of  claim 4 , wherein the operations further comprise:\n determining for a given blood glucose time within a first sequential time interval of the four sequential time intervals or a second sequential time interval of the six sequential time intervals, a given blood glucose measurement that is within one of a plurality of target ranges of values; determining an adjustment factor for adjusting a value of recommended equal-boluses to the patient based on the corresponding target range of values and the given blood glucose measurement; retrieving a previous day's value of recommended equal-boluses; determining a new value of recommended equal-boluses by multiplying the adjustment factor times the previous day's value of recommended equal-boluses; and administering the new value of recommended equal-boluses to the patient by transmitting the new value of recommended equal-boluses from the data processing device to the dose administering system having the patient display at the sequential time intervals, the patient display configured to display a third number of units of insulin corresponding to the new value of recommended equal-boluses and trigger administration of the third number of units of insulin to the patient at each of the sequential time intervals.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 96.0
- Lexical Diversity: 2.125
- Patent Class: 702.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14524756', '15862310', '14938997', '15942740', '14524918']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.368126601241807
- 35 USC 102 Novelty (BERT): 0.6758252591208752
- Combined Prediction Score: 0.3988964670297138
- Mean Citation Score: 664.9779000000002
- Max Citation Score: 694.5615
- Similarity Product: 663.2139837324322

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test